Fingerprint
Dive into the research topics of 'The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma
Nathan H. Fowler, Loretta Nastoupil, Sven De Vos, Mark Knapp, Ian W. Flinn, Robert Chen, Ranjana H. Advani, Sumeet Bhatia, Peter Martin, Raul Mena, Richard Eric Davis, Sattva S. Neelapu, Karl Eckert, Jerry Ping, Melannie Co, Darrin M. Beaupre, Jutta K. Neuenburg, M. Lia Palomba
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations